Phase Ib trial of peginterferon beta

Trial Profile

Phase Ib trial of peginterferon beta

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Oct 2011

At a glance

  • Drugs Peginterferon beta (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 18 Oct 2011 Status changed from recruiting to active, no longer recruiting.
    • 18 Oct 2011 Interim adverse events, pharmacokinetics and pharmacodynamics data from a phase Ib trial in volunteers released by Allozyne.
    • 12 Jan 2011 Results from this trial are expected in mid-2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top